Cargando…

Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer

BACKGROUND: Adoptive transfer of immune cells such as T cells and natural killer (NK) cells has emerged as a targeted method of controlling the immune system against cancer. Despite their significant therapeutic potential, efficient methods to generate adequate numbers of NK cells are lacking and ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jung-Won, Lee, Eui Soo, Kim, Se Young, Park, Su Il, Oh, Sena, Kang, Jung Hwa, Ryu, Hyun Aae, Lee, Seahyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700835/ https://www.ncbi.nlm.nih.gov/pubmed/31426763 http://dx.doi.org/10.1186/s12885-019-6034-1

Ejemplares similares

Real-Time Tracking of Ex Vivo-Expanded Natural Killer Cells Toward Human Triple-Negative Breast Cancers
por: Uong, Tung Nguyen Thanh, et al.
Publicado: (2018)

Padua, the cradle of modern medicine: Bernardino Ramazzini (1633–1714) on headaches
por: Zanchin, G.
Publicado: (2005)

Proteome Analysis of Human Natural Killer Cell Derived Extracellular Vesicles for Identification of Anticancer Effectors
por: Choi, Jung-Won, et al.
Publicado: (2020)

Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7
Publicado: (1992)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Exploring the Variability of the Flat Spectrum Radio Source 1633+382. I. Phenomenology of the Light Curves
por: Algaba, Juan-Carlos, et al.
Publicado: (2017)

1633 The Importance of Considering Different Healthcare Settings When Estimating the Incidence of Clostridium difficile
por: Kuntz, Jennifer, et al.
Publicado: (2014)

1633. Improving the diagnosis of extra-pulmonary tuberculosis (EPTB): experience from north India
por: Sharma, Anchal, et al.
Publicado: (2020)

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions
por: Jung, Daun, et al.
Publicado: (2021)

Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study
por: Kim, Jong Man, et al.
Publicado: (2021)

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
por: Shenouda, Mira M., et al.
Publicado: (2017)

1633P Why do cancer clinical trials (CT) discontinue prematurely in the era of COVID-19?
por: Iannantuono, G.M., et al.
Publicado: (2021)

Ex vivo expansion of human peripheral blood natural killer cells and cytotoxic T lymphocytes from lung cancer patients
por: Nhung, Hoang Thi My, et al.
Publicado: (2018)

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
por: Lieberman, Nicole A. P., et al.
Publicado: (2018)

Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand
por: Oh, Se-Jeong, et al.
Publicado: (2017)

Ex Vivo Expansion of Highly Cytotoxic Natural Killer Cells Using Optimal Culture Medium
por: Kim, Seokho
Publicado: (2022)

Heterogeneous Niche Activity of Ex-Vivo Expanded MSCs as Factor for Variable Outcomes in Hematopoietic Recovery
por: Kim, Jung-Ho, et al.
Publicado: (2016)

Removal of Polytungstate from Mine Wastewater Using a Flat Renewal Membrane Reactor with N1633 as a Carrier
por: Pei, Liang, et al.
Publicado: (2022)

Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma
por: Chu, Yaya, et al.
Publicado: (2020)

Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model
por: Thangaraj, Jaya Lakshmi, et al.
Publicado: (2022)

Phase I Clinical Trial Using Autologous Ex Vivo Expanded NK Cells and Cytotoxic T Lymphocytes for Cancer Treatment in Vietnam
por: Liem, Nguyen Thanh, et al.
Publicado: (2019)

Comment on: Allister et al. UCP2 Regulates the Glucagon Response to Fasting and Starvation. Diabetes 2013;62:1623–1633
por: Gylfe, Erik
Publicado: (2013)

PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells
por: Guo, Yanan, et al.
Publicado: (2016)

In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells
por: Niu, Chao, et al.
Publicado: (2015)

Regulation of the Induction and Function of Cytotoxic T Lymphocytes by Natural Killer T Cell
por: Ito, Hiroyasu, et al.
Publicado: (2010)

GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
por: Lim, Okjae, et al.
Publicado: (2013)

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
por: Lundqvist, Andreas, et al.
Publicado: (2011)

Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy
por: Zhang, Xiaokui, et al.
Publicado: (2015)

Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3(+)CD5(dim)CD21(−) Cytotoxic Large Granular Lymphocytes
por: Lee, Soo-Hyeon, et al.
Publicado: (2018)

Response to Comment on: Allister et al. UCP2 Regulates the Glucagon Response to Fasting and Starvation. Diabetes 2013;62:1623–1633
por: Hardy, Alexandre B., et al.
Publicado: (2013)

Significant differences in demographic, clinical, and pathological features in relation to smoking and alcohol consumption among 1,633 head and neck cancer patients
por: Moyses, Raquel Ajub, et al.
Publicado: (2013)

Large-scale ICU data sharing for global collaboration: the first 1633 critically ill COVID-19 patients in the Dutch Data Warehouse
por: Fleuren, Lucas M., et al.
Publicado: (2021)

Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo
por: Oyer, Jeremiah L., et al.
Publicado: (2022)

Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors
por: Shida, Yoichi, et al.
Publicado: (2021)

Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period
por: Niavarani, Seyedeh Raheleh, et al.
Publicado: (2019)

The effects of indoxyl sulfate-induced endothelial microparticles on neointimal hyperplasia formation in an ex vivo model
por: Ryu, Jung-Hwa, et al.
Publicado: (2017)

1633. A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection in Adults and Children in Emergency Department and Urgent Care Settings (MITIGATE Trial)
por: Yadav, Kabir, et al.
Publicado: (2018)

The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis
por: Lim, Jeong-Ae, et al.
Publicado: (2018)

Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2(+) pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice
por: Chu, Yaya, et al.
Publicado: (2021)

Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro
por: Tanaka, Yoshitaka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jbh084hl7ogn84jes7qi17h2km